N6-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
2020 · Cell Death and Disease · 323 citations
https://doi.org/10.1038/s41419-020-03071-y
Q
Qianqing Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
956
Citations
12
h-index
13
i10-index
Qianqing Wang is an academic researcher from Targeted Medical Pharma (United States). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Endometrial and Cervical Cancer Treatments & Cancer-related molecular mechanisms research. The author has an h-index of 12, co-authored 37 publications.
ORCID: 0009-0009-6780-5325Papers by this author
worksmiR-16-5p/PDK4-Mediated Metabolic Reprogramming Is Involved in Chemoresistance of Cervical Cancer
2020 · Molecular Therapy — Oncolytics · 39 citations
https://doi.org/10.1016/j.omto.2020.05.008
A randomized open-label clinical trial of an anti-HPV biological dressing (JB01-BD) administered intravaginally to treat high-risk HPV infection
2015 · Microbes and Infection · 25 citations
https://doi.org/10.1016/j.micinf.2015.10.004
Fluorescence-guided ureteral identification in robotic surgery for advanced endometriosis: a comparison of junior versus senior surgeons
2025 · Scientific Reports · 4 citations
https://doi.org/10.1038/s41598-025-05082-1
Polypyrimidine tract-binding protein 3/insulin-like growth factor 2 mRNA-binding proteins 3/high-mobility group A1 axis promotes renal cancer growth and metastasis
2024 · iScience · 1 citations
https://doi.org/10.1016/j.isci.2024.109158
Retraction Notice to: Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression
2024 · Molecular Therapy — Nucleic Acids · 1 citations
https://doi.org/10.1016/j.omtn.2024.102213
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat